press releases

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE...

Nov 20, 2024

Rapid, accurate detection of six gastrointestinal disease-causing pathogens in cats and dogs Eastleigh, UK, 14 November 2024: ...

Nov 14, 2024

Offers clinicians and patients additional confidence in quality and accuracy of test for cystic fibrosis diagnosis Manchester, UK, 17...

Oct 17, 2024